A Smart + Strong Site
Subscribe to:
POZ magazine

Back to home » Treatment News » Top Stories

November 25, 2015
CDC Says 1.2 Million Americans Are Likely Candidates for PrEP
The CDC has estimated that 1.2 million Americans are candidates for Truvada as PrEP and should be counseled about the HIV prevention method.
November 24, 2015
Anti-Alcoholism Drug Wakes Cells Latently Infected With HIV
The anti-alcoholism drug Antabuse (disulfiram) prompts cells latently infected with HIV to replicate, a finding that could contribute to a strategy for curing the virus.
Mon Dieu, France Approves PrEP!
France has become the first country outside of the United States to approve use of Truvada as pre-exposure prophylaxis (PrEP) to prevent HIV.
November 23, 2015
No Drop in Hep C Rates Among European Gays With HIV
Hepatitis C acquisition among HIV-positive European gay and bi men has steadily increased during the past 25 years, although trends vary by region, with evidence of a recent leveling-off effect in Western Europe.
November 20, 2015
AIDS-Related Deaths Have Fallen in South Africa
The introduction of antiretroviral treatment in South Africa in the mid-2000s reversed what had been a steadily rising AIDS-related death rate in that hard-hit nation.
Daklinza & Sovaldi Better Treats Those With HIV & HCV
Daklinza (daclatasvir) and Sovaldi (sofosbuvir) more effectively cures hepatitis C among those coinfected with HIV than does Sovaldi and ribavirin.
November 19, 2015
Having the Sex Talk With Teens Encourages Safer Sex
Discussions about safer sex between parents and their adolescent children have a modest but significant effect on safer sex practices among teens.
November 18, 2015
U.S. Uninsured Map Troublingly Similar to HIV Prevalence Map
A New York Times map detailing the varying rates of uninsured people shows striking similarities to the distribution of people living with HIV in the United States.
November 17, 2015
Chlamydia, Gonorrhea and Syphilis Are All On the Rise
The U.S. sexually transmitted infection epidemic is expanding, in some cases at an “alarming rate,” according to the Centers for Disease Control and Prevention (CDC).
Hepatitis C May Transmit Sexually From Rectum Without Blood
Men may acquire hepatitis C virus sexually from the rectums of HIV/HCV-coinfected men even when there is no blood present.
November 16, 2015
Very Low HIV Rate in Study of High-Risk Gays on PrEP
A major American real-world study of PrEP among high-risk men who have sex with men has seen a very low HIV rate despite a high rate of other STIs.
November 13, 2015
FDA OKs Harvoni for Hep C Genotypes 4, 5, 6, People With HIV
The FDA has approved new indications for Gilead’s Harvoni: to treat hepatitis C in those with genotypes 4–6 of the virus and in those coinfected with HIV.
November 12, 2015
‘PrEP Works if You Take It’ for Trans Women Too
Truvada (tenofovir/emtricitabine) as pre-exposure prophylaxis (PrEP) protects transgender women against HIV if they take it consistently.
November 11, 2015
Poor Results for New Syringe Designed to Curb Hep C Spread
A new type of syringe apparently falls short at lowering the risk of hepatitis C virus transmission.
Drug-Resistant Gonorrhea Rising Once More
After dropping dramatically in recent years, rates of drug-resistant gonorrhea rose once again in 2014.
November 10, 2015
Europe Finds No Link Between Two Syndromes and HPV Vaccines
According to the European Medicines Agency, there is no link between any of the versions of the human papillomavirus (HPV) vaccine and two syndromes.
November 09, 2015
Four- and Eight-Week HIV Treatments Show Promise
Long-acting injections of a dual-combination HIV treatment, given every four or eight weeks, suppressed the virus as well as an oral regimen.
November 05, 2015
Infections Lead to Many Cancers Among People With HIV
A considerable proportion of the cancer burden among HIV-positive Americans derives from infections.
FDA OKs Gilead's Genvoya, First HIV Combo Pill With New Tenofovir
The FDA has approved Gilead’s single-tablet antiretroviral regimen Genvoya, the first HIV treatment to include a new version of tenofovir.
November 04, 2015
Starting HIV Treatment Earlier Translates to More Bone Loss
Those who begin HIV treatment soon after diagnosis experience more bone loss than those who defer taking antiretrovirals until HIV disease has progressed.
November 03, 2015
HIV Essentially Doubles Aging’s Effect on Heart Attack Risk
Every decade spent living with HIV is equivalent to an additional 10 years of ordinary aging’s contribution to heart attack risk.
November 02, 2015
Curing Hep C Lowers Risk of Death in Those Coinfected With HIV
People coinfected with HIV and hepatitis C have a much lower risk of death after being cured of hep C.
Statins Slow Liver Disease in People With HIV and HCV
Non-cirrhotic people coinfected with HIV and hepatitis C are much less likely to experience liver disease progression if they are taking a statin.
Most Popular Stories
Undetectable Viral Load Essentially Eliminates Transmission Risk in Straight Couples
FDA Approves New Single-Tablet HIV Regimen, Triumeq
Life Expectancy for Young People With HIV Is Nearly Normal
A 15-Year Jump in Life Expectancy for People With HIV
Scientists Devise Method of Snipping HIV From Immune Cells
Monkey HIV Vaccine Success Opens Door for Human Trials
HIV Combo Pill Less Toxic Thanks to New Form of Tenofovir
Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?

November 2015
October 2015
September 2015
August 2015
July 2015
June 2015
May 2015
April 2015
March 2015
February 2015
January 2015
December 2014
November 2014
October 2014
September 2014
August 2014
July 2014
June 2014
May 2014
April 2014
March 2014
February 2014
January 2014
December 2013
November 2013
October 2013
September 2013
August 2013
July 2013
June 2013
May 2013
April 2013
March 2013
February 2013
January 2013
December 2012
November 2012
October 2012
September 2012
August 2012
July 2012
June 2012
May 2012
April 2012
March 2012
February 2012
January 2012
December 2011
November 2011
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
January 2011
December 2010
November 2010
October 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007
January 2007
December 2006
November 2006
October 2006
September 2006
August 2006
July 2006
June 2006
May 2006
April 2006
February 2006
October 2005

Quick Links
About HIV and AIDS
The Cure
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Conference Coverage
Health Services Directory
POZ Magazine
AIDSmeds on Twitter

Conference Coverage

XX International AIDS Conference
(AIDS 2014)
Melbourne, Australia
July 20 - 25, 2014

21st Conference on Retroviruses and Opportunistic Infections
(CROI 2014)
Boston, MA
March 3 - 7, 2014

7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention
(IAS 2013)
Kuala Lumpur, Malaysia
June 30 - July 3, 2013

more conference coverage

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2015 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.